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This report examines the characteristics and trends of dialysis and renal transplant patients among the resident 
population of Hong Kong who were managed by hospitals or dialysis centers of the Hospital Authority of 
Hong Kong, and who accounted for approximately 95% of all patients who received renal replacement therapy 
(RRT) in the territory. Patients who received RRT solely in the private sector were not included in this report. 
Data trends from 1996 to 2009 are presented.
In 2009, 930 new patients were accepted into RRT programs and the incident rate was 132.4 patients per 
million population (pmp). This is lower than the incident rate in 2008, which was 148.2 pmp. The point preva-
lence as of December 31, 2009 was 7,580, with a prevalence rate of 1,078.8 pmp. There were 3,401 patients on 
peritoneal dialysis (PD, 44.9%), 945 patients on hemodialysis (HD, 12.5%), and 3,234 patients living with a 
functioning renal transplant. The PD to HD ratio was 81.5:18.5 for patients on dialysis treatment at Hospital 
Authority centers. PD-first policy continued.
The overall mortality rate among RRT patients was 10.7 patients per 100 patient-years exposed. There was 
a decreasing trend in mortality among PD patients. Infection and cardiovascular complications were the most 
common causes of death. Renal transplant was the modality with the best survival. The 5-year cumulative patient 
survival rate for patients on transplant treatment was 88%, whereas the corresponding patient survival rates for 
PD and HD patients were 37% and 34.2%, respectively.
More than 80% of RRT patients with reports on rehabilitation were active and had normal activities. 
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INTRODUCTION
This report is based on data up to December 31, 2009 
of dialysis and renal transplant patients from the Renal 
Registry of the Hospital Authority (HA) of Hong Kong, 
and accounts for 90–95% of all patients who received 
renal replacement therapy (RRT) in the territory. Patients 
who received RRT solely in the private sector were not 
included in this report. There are 11 renal units, two 
satellite centers and four renal transplant clusters in 
Hong Kong (Table).
The Renal Registry was implemented in the HA in 
April 1995. It is an online registry with data entered 
directly into it through Clinical Management System 
terminals in HA wards or clinics or through dedicated 
computer terminals in renal units. With the dedicated 
computer terminals, patient data for the individual renal 
unit can be retrieved and saved for service planning 
and patient management use. The registry is also used 
by the HA Head Office for RRT service planning and 
resource allocation. As data are entered online and renal 
units can update their patient data at any time, there may 
be minor discrepancies in the figures retrieved.
The Renal Registry is linked with other computer 
systems such as the Organ Procurement System and 
the Transplantation & Immunogenetics Laboratory 
System for organ allocation in deceased donor renal 
transplantation.
The renal registry collects data from hospital dialysis 
and transplant programs from patients’ first RRT treatment 
for end-stage renal failure (ESRF; dialysis or transplan-
tation) to their death, unless they were lost to follow-up. 
Only treatments provided in Hong Kong under the HA 
are included in this report. Data are on a calendar-year 
basis (January 1 to December 31).
THE INCIDENT PATIENTS
In the year ending December 31, 2009, there were 930 
newly diagnosed patients with ESRF accepted into di-
alysis programs or who received preemptive renal 
transplants. The incidence rate was 132.4 per million 
population (pmp). There was a decrease in the number 
of patients accepted into RRT programs in the year 2009 
compared with preceding years (the trend from 1996 to 
2009 is shown in Figure 1). This coincided with the pro-
motion of advance care planning and supportive care for 
patients who did not want RRT in the management of 
ESRF. The decline in acceptance of peritoneal dialysis 
(PD) was more marked.
The mean and median age for incident RRT patients 
for the year 2009 were 57.7 and 58.3 years, respectively. 
The mean and median age for incident PD patients were 
59.9 and 60.0 years, respectively. In the year 2009, there 
was a decrease in the number of patients aged 65 or older 
who accepted RRT (Figure 2).
For the period 1996–2009, the mean and median 
age for incident patients on PD and hemodialysis (HD), 
and those who received renal transplant increased 
gradually (Figures 3 and 4). This was in line with the 
increase in the age of the population in Hong Kong. 
There were more male than female patients accepting 
RRT (Figure 5).
Diabetes remained the most common primary etiology 
leading to ESRF and acceptance of RRT, accounting for 
46.2% of cases; 20.2% of the primary etiology was due 
to glomerulonephritis. Hypertension and other vascular 
causes were responsible for 9.6% (Figure 6). There was 
an increasing percentage of patients with a primary di-
agnosis of diabetes mellitus being responsible for their 
ESRF. The percentage of diabetes mellitus among inci-
dent patients increased by 15% in 10 years, from 31.4% 
in 1999 to 46.2% in 2009.
Table. Renal centers and transplant clusters in Hong Kong
Hospital cluster Renal centers
Hong Kong West • Queen Mary Hospital
 • Tung Wah Hospital
Hong Kong East •  Pamela Youde Nethersole Eastern 
Hospital
Kowloon Central • Queen Elizabeth Hospital
 • Yau Ma Tei Satellite Center
Kowloon East • United Christian Hospital
 • Tseung Kwan O Hospital
Kowloon West • Princess Margaret Hospital
 • Kwong Wah Hospital
 • Yan Chai Hospital
 • Caritas Medical Center
New Territories East • Prince of Wales Hospital
 •  Alice Ho Miu Ling Nethersole 
Hospital
New Territories West • Tuen Mun Hospital
 • Yan Oi Satellite Center
Transplant cluster hospitals
Queen Mary • Queen Mary Hospital
 Hospital Cluster • Tung Wah Hospital
 •  Pamela Youde Nethersole Eastern 
Hospital
 • Kwong Wah Hospital
Queen Elizabeth • Queen Elizabeth Hospital
 Hospital Cluster • Yau Ma Tei Satellite Center
 • United Christian Hospital
Princess Margaret • Princess Margaret Hospital
 Hospital Cluster • Yan Chai Hospital
 • Caritas Medical Center
 • Tuen Mun Hospital
 • Yan Oi Satellite Center
Prince of Wales • Prince of Wales Hospital
 Hospital Cluster •  Alice Ho Miu Ling Nethersole 
Hospital
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Figure 2. Age-stratified trends in incident counts by calendar year, 1996–2009.
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Figure 1. Incident rates (per million population) by calendar year of patients accepted into RRT programs, 1996–2009. RRT = renal 
replacement therapy; PD = peritoneal dialysis; HD = hemodialysis; RTx = renal transplant.
THE POINT PREVALENT PATIENTS
As of December 31, 2009, 7,580 people were registered 
in the Renal Registry for RRT treatment, with less than 
half (44.9%, n = 3,401) receiving PD, followed by 42.7% 
(3,234) living with a functioning kidney transplant, and 
945 (12.5%) being treated with HD (Figure 7). The 
prevalent rate of RRT as of December 31, 2009 was 
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1,078.8 pmp. There was an increasing trend in prevalence 
rates from 1996 to 2009 (Figure 8).
The profile of prevalent ESRF patients in Hong Kong 
has gradually changed over time. While at the end of 
2009, the largest category of RRT patients were those 
receiving PD (44.9%), the proportion of patients on PD 
has decreased compared to previous years (Figure 8), and 
the proportion of patients with functioning renal trans-
plants has increased. In 1996, 28.9% of RRT patients 
had functioning renal transplants. This had increased to 
42.7% in 2009. There was also a gradual increase in the 
provision of HD services in the territory. Now, in addition 
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Figure 3. Trends in mean age for incident RRT patients, 1996–2009. PD = peritoneal dialysis; HD = hemodialysis; RRT = renal replacement 
therapy; RTx = renal transplant.
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Figure 4. Trends in median age for incident RRT patients, 1996–2009. PD = peritoneal dialysis; HD = hemodialysis; RRT = renal replacement 
therapy; RTx = renal transplant.
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to HD services provided by HA centers, a proportion of 
patients receiving HD at charitable and private centers 
are followed-up at HA renal units.
The proportion of HD to PD among dialysis patients 
increased slightly from 20.8:79.2 in 1999 to 21.7:78.3 in 
2009 (Figure 9). When examining dialysis treatment in 
HA centers only, the ratio was 17.5:82.5 in 1996 and 
18.5:81.5 in 2009 (Figure 10). Moreover, in terms of 
patient-years on treatment, a change in proportion was 
also evident; the HD:PD ratio was 18:82 in 1999 and 
23:77 in 2009 (Figure 11).
PD
The PD-first policy has continued in Hong Kong. As 
of December 31, 2009, 3,401 patients were on various 
types of PD treatment with a prevalence of 484 pmp, 
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Figure 5. Sex distribution of incident patients, 1996–2009.
Figure 6. Diagnosis distribution (% incident counts) of patients, 1996–2009.
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comprising 78.3% of the dialysis population. The major-
ity of PD patients received continuous ambulatory PD 
(CAPD; n = 3,131, 92%; Figure 12). Moreover, the 
proportion of patients on automated PD (continuous 
cyclic PD, n = 112, 3.3%; and nocturnal intermittent PD, 
n = 158, 4.7%) has increased steadily in the past 5 years 
(Figure 13). On the other hand, the number of CAPD 
patients showed negative growth in the year 2009. From 
the year 2000 onwards, there was gradual switching of 
connecting PD systems to disconnect systems. By 2009, 
all patients on PD were on disconnect systems.
HD
The majority of HD patients in Hong Kong switch from 
PD. There was a steady increase in the provision of HD 
services, and home HD in the form of nocturnal home 
HD was reintroduced (Figure 14). As of December 31, 
2009, 642 patients (67.9%) were on regular HD in the 
Renal transplant, 42.66%Hemodialysis, 12.47%
Peritoneal dialysis, 44.87%
Figure 7. Point prevalent distribution of renal replacement therapy 
patients registered in the Hong Kong Renal Registry as of December 
31, 2009.
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Figure 8. Trends in point prevalent distribution of renal replacement therapy (RRT), 1996–2009. PD = peritoneal dialysis; RTx = renal 
transplant; HD = hemodialysis.
HA hospital setting, 77 (8.2%) were on HD at satellite 
centers, 26 patients (2.8%) were on home HD, and 172 
(21.1%) were dialyzed at charitable or private HD cen-
ters. The prevalence of HD was 134.4 pmp, comprising 
21.7% of all dialysis patients.
Kidney transplantation
The proportion of patients with functioning grafts con-
tinued to increase (Figure 15), comprising 42.7% of RRT 
patients in 2009, with a prevalence of 460.3 pmp. Ten 
years ago, in 1999, the corresponding figures were 30.2% 
and 205 pmp, respectively. Among the 3,234 patients 
with functioning grafts on December 31, 2009, 1,023 
(31.6%) had undergone transplantation in Hong Kong 
while the other transplantations had been performed 
overseas. Of the transplantations done in Hong Kong, 
670 (65.5%) were deceased donor renal transplantations 
(DDRT) and 353 (34.5%) were living donor renal trans-
plantations (LDRT).
In the year ending December 31, 2009, 241 patients 
commenced transplant treatment; among them, 87 were 
DDRT procured from among HA hospitals. There was 
an increasing trend in deceased donor kidney procure-
ment from 1996 to 2009, resulting in a higher prevalence 
of DDRT patients in the functioning transplant pool 
(Figure 16). A review on living donor procurement in 
Hong Kong may be necessary as the number of new 
LDRT appears to be decreasing.
Erythropoietin
The number of patients on erythropoietin treatment is 
grossly underreported in the renal registry because manual 
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Figure 10. PD:HD ratio for dialysis patients in Hospital Authority centers, 1996–2009. HD = hemodialysis; PD = peritoneal dialysis.
input is required. The prescription of erythropoiesis-
stimulating agents has been increasing steadily. In 1996, 
29.3% of dialysis patients were reported to be on eryth-
ropoietin. In 2009, the reported proportion reached 
beyond 45% (Figure 17).
Diagnosis and comorbidities
The pattern of disease and comorbidities changed with 
the changing environment and aging community. Dia-
betes is currently the leading primary diagnosis among 
ESRF patients. In prevalent patients, the proportion 
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Figure 9. PD:HD ratio for all registered patients in Hospital Authority, including HD in charitable and private centers, 1996–2009. 
HD = hemodialysis; PD = peritoneal dialysis.
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of diabetes and hypertension increased from 12.9% 
and 3.6%, respectively, in 1996 to 24.6% and 7.6%, 
respectively, in 2009 (Figure 18). The proportions 
of other diagnoses remained similar throughout the 
years. The prevalence of hepatitis C virus carriers de-
creased from 7% in 1996 to 2.5% in 2009, while the 
prevalence of hepatitis B virus carriers was similar to 
that in our local population, which was 9.9% in 2009. 
When diabetes was regarded as a comorbidity, prevalent 
patients increased from 20.6% in 1996 to 31.6% in 2009 
(Figure 19).
OUTCOMES
Mortality rates were calculated by counting the number 
of deaths by patient-years exposed. The mortality rates 
for patients on PD, HD and renal transplant were 19.11, 
15.0 and 1.70 deaths per 100 patient-years in 2009. The 
overall mortality rate was 10.38 deaths per 100 patient-
years.
There was a decreasing trend in mortality in PD pa-
tients, whereas the mortality of transplant recipients in-
creased in the past 3 years (Figure 20). Better dialysis 
care and patient decisions on either dialysis or supportive 
management might be the reason behind the improve-
ment in PD. The higher mortality among transplant re-
cipients might be a reflection of the fact that more and 
more elderly patients have been receiving DDRT in the 
past few years.
Infection and cardiovascular deaths were the most 
common causes of deaths. There was an increase in “un-
known cause of death” being reported to the registry in 
the past 3 years (Figure 21).
As for patient survival, there was significant varia-
tion among different age groups of PD patients. The 
overall median survival was 3.9 years. The cumulative 
1- and 5-year patient survival for those aged 20–44 were 
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Figure 11. PD:HD ratio (% patient-years) for patients in Hospital Authority centers, 1999–2009. PD = peritoneal dialysis; HD = 
hemodialysis.
CAPD, 92.06%
NIPD, 4.65%CCPD, 3.29%
Figure 12. Distribution of different types of peritoneal dialysis 
(PD) as of December 31, 2009. CAPD = continuous ambulatory PD; 
CCPD = continuous cyclic PD; NIPD = nocturnal intermittent PD.
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94% and 64%, respectively, whereas for patients aged 
65–74, the corresponding figures for cumulative survival 
were 87% and 25%, respectively (Figure 22).
Disconnect systems were introduced gradually in 
the late 1990s. We compared the registry data of patients 
who commenced PD between 1995 and 1999 when the 
majority of patients were on connect systems with data 
from 2000 to 2005 when most patients were on disconnect 
systems. The 1-year cumulative patient survival rates 
were 87% and 90% for the connect and disconnect sys-
tems, respectively, whereas the 3-year cumulative survival 
rates were 59% and 64%, and the 5-year cumulative sur-
vival rates were 35% and 38%, respectively. Patients who 
commenced PD during the latter time period survived 
better (Figure 23).
Among the 3,401 prevalent PD patients as of 
December 31, 2009, 112 of them had been on PD for 
10 years or more. Among these 112 patients, 15 had 
Figure 13. Trends (prevalent counts) in the different types of peritoneal dialysis (PD), 1999–2009. CAPD = continuous ambulatory PD; 
NIPD = nocturnal intermittent PD; CCPD = continuous cyclic PD.
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Figure 14. Trends (prevalent counts) in the different types of hemodialysis (HD), 1996–2009.
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Figure 15. Trends (prevalent counts) in renal transplantation, 1996–2009. LDRT = living donor renal transplantation; DDRT = deceased 
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been on PD for 15–20 years and two for more than 
20 years.
The overall peritonitis rate for CAPD has improved 
from 22 patient-months per episode in 1996 to 31.8 
patient-months per episode in 2009. There were varia-
tions in peritonitis rates between different dialysis sys-
tems and the trends from 1999 to 2009 are presented in 
Figure 24. In 2009, patients on nocturnal intermittent PD 
performed best, with a peritonitis rate of 69.8 patient-
months per episode (Figure 24).
The pattern of microorganisms has remained re-
latively constant throughout 1999 to 2009 (Figure 25). 
In 2009, 47% were Gram-positive organisms, 36% 
were Gram-negative organisms, and 12.6% were 
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Figure 17. Trends in the number and percentage of dialysis patients on erythropoietin (EPO), 1996–2009.
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Figure 18. Distribution (% prevalent patient counts) of primary diagnoses, 1996–2009.
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culture-negative. On closer examination of the data, 
there were decreasing trends from 1999 to 2009 in the 
reported cases of methicillin-resistant Staphylococcus 
aureus and Pseudomonas species (Figure 26).
For HD patients who commenced treatment between 
1995 and 2005, the overall 1-year cumulative patient sur-
vival rate was 72.4%, 3-year patient survival was 51.4%, 
and 5-year patient survival was 34.2%; median survival 
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Figure 19. Comorbidities (hepatitis B virus, hepatitis C virus, diabetes mellitus) among prevalent patients, 1996–2009.
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Figure 20. Annual mortality rates per 100 patient-years, 1999–2009. RTx = renal transplant; HD = hemodialysis; PD = peritoneal dialysis; 
RRT = renal replacement therapy.
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time was 3.2 years. When patients who commenced HD 
between 1995 and 1999 were compared with those who 
started HD between 2000 and 2005, the former group 
of patients survived longer, although the median survival 
time of both groups was 3.2 years (Figure 27).
For patients who received DDRT in Hong Kong be-
tween 1995 and 2005, 1-year patient survival was 94.0%, 
3-year survival was 90.9%, 5-year survival was 88%, 
and 10-year survival was 81.7%. The corresponding graft 
survivals (death not censored) were 88.2%, 83.4%, 
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Figure 21. Trends in cause of death for all renal replacement therapy patients, 1999–2009.
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Figure 22. Age-stratified peritoneal dialysis patient survival, 1995–2005.
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Figure 23. Peritoneal dialysis (PD) patient survival, 1995–2005, stratified by time of PD commencement (1995–1999 vs. 2000–2005).
Figure 24. Trends in peritoneal dialysis (PD) peritonitis rates (patient-months per episode), 1999–2009. CAPD = continuous ambulatory 
PD; NIPD = nocturnal intermittent PD; CCPD = continuous cyclic PD; APD = automated PD.
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Figure 25. Trends in causative microorganisms of peritonitis due to continuous ambulatory peritoneal dialysis, 1999–2009.
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Figure 26. Common microorganisms involved in continuous ambulatory peritoneal dialysis peritonitis, 1999–2009. MSSA = methicillin-
sensitive Staphylococcus aureus; MRSA = methicillin-resistant Staphylococcus aureus.
78.0% and 64.8%, respectively. When graft survivals 
(death not censored) of LDRT were compared with that 
of DDRT, LDRT showed significantly better survival 
rates: 1-year graft survival was 93.7%, 3-year graft 
survival was 93.2%, 5-year graft survival was 90.5%, 
and 10-year graft survival was 81% (Figure 28). The 
5- and 10-year patient survival rates for LDRT were 
96.2% and 92.3%, respectively, significantly better than 
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the rates for patients who underwent DDRT (p = 0.026, 
log rank test).
Rehabilitation
Work and daily activity status were recorded in the renal 
registry. From records for the last 11 years, about 80% of 
our patients worked full time or part time, or played the 
role of a housewife, or were retired. Disinclination to 
work and absence from school were a minority (Figure 
29). More than 80% of patients had normal activities. 
Less than 10% of patients required assistance in their 
activities of daily living (Figure 30).
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Figure 27. Hemodialysis (HD) patient survival, 1995–2005, stratified by time of HD commencement (1995–1999 vs. 2000–2005).
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Figure 28. Graft survival, death not censored, living donor renal transplantation (LDRT) versus deceased donor renal transplantation 
(DDRT), 1995–2005.
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DISCUSSION
The PD-first policy has been maintained in Hong Kong, 
and this has allowed high prevalent rates of RRT. The 
number of patients commencing PD had declined in 
2009, whereas the number of patients on HD and who 
received transplants increased. Diabetes was the prin-
ciple diagnosis of ESRF leading to RRT, and the increas-
ing trend continued. The future goal of the medical and 
nephrology community should include better manage-
ment of diabetic patients and the prevention of renal 
failure.
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Figure 29. Work status of all adult renal replacement therapy patients, 1999–2009.
Figure 30. Daily activities of living status of all adult renal replacement therapy patients, 1999–2009.
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NOTE
It is important to note that all the data presented in this 
report is subject to change based on future data updates 
or corrections. The analytical conventions used in this 
report may vary from previously published reports. 
Discrepancies from previously published reports may 
reflect database updates and/or differences in analytical 
approaches.
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